Literature DB >> 30729360

Pre-diagnostic carbohydrate intake and treatment failure after radical prostatectomy for early-stage prostate cancer.

Kyeezu Kim1, Angela Kong2, Robert C Flanigan3, Marcus L Quek3, Courtney M P Hollowell4, Patricia P Vidal4, Jefferey Branch5, Leslie A Dean6, Virgilia Macias7, Andre A Kajadacsy-Balla7, Marian L Fitzgibbon8, Daisy Cintron8, Li Liu1, Vincent L Freeman9,10.   

Abstract

PURPOSE: An association between dietary carbohydrate intake and prostate cancer (PCa) prognosis is biologically plausible, but data are scarce. This prospective cohort study examined the relation between pre-diagnostic carbohydrate intake and treatment failure following radical prostatectomy for clinically early-stage PCa.
METHODS: We identified 205 men awaiting radical prostatectomy and assessed their usual dietary intake of carbohydrates using the 110-item Block food frequency questionnaire. We also evaluated carbohydrate intake quality using a score based on the consumption of sugars relative to fiber, fat, and protein. Logistic regression analyzed their associations with the odds of treatment failure, defined as a detectable and rising serum prostate-specific antigen (PSA) or receiving androgen deprivation therapy (ADT) within 2 years.
RESULTS: Sucrose consumption was associated with a higher odds and fiber consumption with a lower odds of ADT after accounting for age, race/ethnicity, body mass index, and tumor characteristics (odds ratio [OR] (95% confidence interval [CI]) 5.68 (1.71, 18.9) for 3rd vs. 1st sucrose tertile and 0.88 (0.81, 0.96) per gram of fiber/day, respectively). Increasing carbohydrate intake quality also associated with a lower odds of ADT (OR (95% CI) 0.78 (0.66, 0.92) per unit increase in score, range 0-12).
CONCLUSIONS: Pre-diagnostic dietary carbohydrate intake composition and quality influence the risk of primary treatment failure for early-stage PCa. Future studies incorporating molecular aspects of carbohydrate metabolism could clarify possible underlying mechanisms.

Entities:  

Keywords:  Dietary carbohydrate; Insulin sensitivity; Prostate cancer prognosis; Treatment failure

Mesh:

Substances:

Year:  2019        PMID: 30729360      PMCID: PMC6436977          DOI: 10.1007/s10552-019-1134-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  39 in total

1.  Prostate cancer risk and serum levels of insulin and leptin: a population-based study.

Authors:  A W Hsing; S Chua; Y T Gao; E Gentzschein; L Chang; J Deng; F Z Stanczyk
Journal:  J Natl Cancer Inst       Date:  2001-05-16       Impact factor: 13.506

2.  Increased serum insulin associated with increased risk of prostate cancer recurrence.

Authors:  Steven Lehrer; Edward J Diamond; Sharodka Stagger; Nelson N Stone; Richard G Stock
Journal:  Prostate       Date:  2002-01-01       Impact factor: 4.104

Review 3.  Role of the insulin-like growth factor family in cancer development and progression.

Authors:  H Yu; T Rohan
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

4.  Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome.

Authors:  V Mohamed-Ali; J H Pinkney; A Panahloo; S Cwyfan-Hughes; J M Holly; J S Yudkin
Journal:  Clin Endocrinol (Oxf)       Date:  1999-02       Impact factor: 3.478

5.  Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.

Authors:  Milena Braga-Basaria; Adrian S Dobs; Denis C Muller; Michael A Carducci; Majnu John; Josephine Egan; Shehzad Basaria
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

6.  Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis.

Authors:  Stephen J Freedland; John Mavropoulos; Amy Wang; Medha Darshan; Wendy Demark-Wahnefried; William J Aronson; Pinchas Cohen; David Hwang; Bercedis Peterson; Timothy Fields; Salvatore V Pizzo; William B Isaacs
Journal:  Prostate       Date:  2008-01-01       Impact factor: 4.104

7.  Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival.

Authors:  Tung H Ngo; R James Barnard; Pak-Shan Leung; Pinchas Cohen; William J Aronson
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

8.  Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.

Authors:  Vasundara Venkateswaran; Ahmed Q Haddad; Neil E Fleshner; Rong Fan; Linda M Sugar; Rob Nam; Laurence H Klotz; Michael Pollak
Journal:  J Natl Cancer Inst       Date:  2007-11-27       Impact factor: 13.506

Review 9.  Dietary intervention strategies to modulate prostate cancer risk and prognosis.

Authors:  Stephen J Freedland; William J Aronson
Journal:  Curr Opin Urol       Date:  2009-05       Impact factor: 2.309

10.  A prospective analysis of the association between dietary fiber intake and prostate cancer risk in EPIC.

Authors:  Reiko Suzuki; Naomi E Allen; Timothy J Key; Paul N Appleby; Anne Tjønneland; Nina Føns Johnsen; Majken K Jensen; Kim Overvad; Heiner Boeing; Tobias Pischon; Rudolf Kaaks; Sabine Rohrmann; Antonia Trichopoulou; Gesthimani Misirli; Dimitrios Trichopoulos; H Bas Bueno-de-Mesquita; Fränzel van Duijnhoven; Carlotta Sacerdote; Valeria Pala; Domenico Palli; Rosario Tumino; Eva Ardanaz; José Ramón Quirós; Nerea Larrañaga; Maria-José Sánchez; María-José Tormo; Paula Jakszyn; Ingegerd Johansson; Pär Stattin; Göran Berglund; Jonas Manjer; Sheila Bingham; Kay-Tee Khaw; Lars Egevad; Pietro Ferrari; Mazda Jenab; Elio Riboli
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.